Research Paper | Pharmaceutical Science | Uzbekistan | Volume 9 Issue 5, May 2020
Study of Embryotoxic and Teratogenic Action of the Medicinal Form of Capsule UROCONITE-0.2 G
Ganieva Z.B., Fayzieva Z.T.
Abstract: The authors studied the embryotoxic and teratogenic effects of the capsule Uroconite-0.2 g. The results of the study proved that the studied capsule - Uroconite-0.2 g in doses of 100 and 500 mg/kg does not adversely affect the development of the fetus in experimental animals. Therefore, the capsule Uroconite-0.2 g does not involve embryotoxic and teratogenic effects.
Keywords: Uroconite-02 g, embryotoxicity, teratogenicity, fetus, pathology and anomalies
Edition: Volume 9 Issue 5, May 2020,
Pages: 1149 - 1151
How to Cite this Article?
Ganieva Z.B., Fayzieva Z.T., "Study of Embryotoxic and Teratogenic Action of the Medicinal Form of Capsule UROCONITE-0.2 G", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=SR20419122222, Volume 9 Issue 5, May 2020, 1149 - 1151
How to Share this Article?
Similar Articles with Keyword 'g'
Drug Utilization Evaluation of Antiepileptic Drugs in a Tertiary Care Hospital
Nethaji Ramalingam, Anuroop Jose, Arun S, Arya Shihab, Devika S, Sudeep Balakrishnan, Babu Ganesan